141 related articles for article (PubMed ID: 38641602)
21. Chronic comorbidities and cervical cancer screening and adherence among US-born and foreign-born women.
Cofie LE; Hirth JM; Wong R
Cancer Causes Control; 2018 Nov; 29(11):1105-1113. PubMed ID: 30353481
[TBL] [Abstract][Full Text] [Related]
22. Low uptake of cervical cancer screening among HIV positive women in Gondar University referral hospital, Northwest Ethiopia: cross-sectional study design.
Nega AD; Woldetsadik MA; Gelagay AA
BMC Womens Health; 2018 Jun; 18(1):87. PubMed ID: 29879969
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
Layet F; Murungi T; Ashaba N; Kigongo E; Opollo MS
BMC Womens Health; 2024 Feb; 24(1):114. PubMed ID: 38347497
[TBL] [Abstract][Full Text] [Related]
24. Real-World Cervical Cancer Screening Uptake and Predictors of Visual Inspection With Acetic Acid Positivity Among Women Living With HIV in Care Programs in Western Kenya.
Mungo C; Orang'o O; Ofner S; Musick B; Yiannoutsos C; Cohen CR; Brown D; Wools-Kaloustian K; Semeere A
JCO Glob Oncol; 2024 Feb; 10():e2300311. PubMed ID: 38359369
[TBL] [Abstract][Full Text] [Related]
25. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
26. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
[TBL] [Abstract][Full Text] [Related]
27. Effect of an Intervention in General Practice to Increase the Participation of Immigrants in Cervical Cancer Screening: A Cluster Randomized Clinical Trial.
Møen KA; Kumar B; Igland J; Diaz E
JAMA Netw Open; 2020 Apr; 3(4):e201903. PubMed ID: 32236530
[TBL] [Abstract][Full Text] [Related]
28. Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: three public policy implications.
Lyimo FS; Beran TN
BMC Public Health; 2012 Jan; 12():22. PubMed ID: 22233530
[TBL] [Abstract][Full Text] [Related]
29. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.
Mwanahamuntu MH; Sahasrabuddhe VV; Blevins M; Kapambwe S; Shepherd BE; Chibwesha C; Pfaendler KS; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Stringer JS; Parham GP
PLoS One; 2013; 8(9):e74607. PubMed ID: 24058599
[TBL] [Abstract][Full Text] [Related]
30. Do vulnerable groups access prevention services? Cervical cancer screening and HIV testing among homeless migrant women in the Paris metropolitan area.
Poncet L; Panjo H; Ringa V; Andro A
PLoS One; 2021; 16(8):e0255900. PubMed ID: 34388200
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania.
Cunningham MS; Skrastins E; Fitzpatrick R; Jindal P; Oneko O; Yeates K; Booth CM; Carpenter J; Aronson KJ
BMJ Open; 2015 Mar; 5(3):e005828. PubMed ID: 25757944
[TBL] [Abstract][Full Text] [Related]
32. The determinants of cervical cancer screening uptake in women with obesity: application of the Andersen's behavioral model to the CONSTANCES survey.
Franck JE; Ringa V; Cœuret-Pellicer M; Chauvin P; Menvielle G
Cancer Causes Control; 2020 Jan; 31(1):51-62. PubMed ID: 31797124
[TBL] [Abstract][Full Text] [Related]
33. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
Chan YM; Ismail MZH; Khaw WF
BMC Womens Health; 2023 Jul; 23(1):389. PubMed ID: 37491253
[TBL] [Abstract][Full Text] [Related]
35. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
[TBL] [Abstract][Full Text] [Related]
36. Improving uptake of cervical cancer screening services for women living with HIV and attending chronic care services in rural Malawi.
Talama GC; Shaw M; Maloya J; Chihana T; Nazimera L; Wroe EB; Kachimanga C
BMJ Open Qual; 2020 Sep; 9(3):. PubMed ID: 32928783
[TBL] [Abstract][Full Text] [Related]
37. HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis.
Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Silas O; Sagay AS; Anorlu R; Mehta SD; Wehbe F; Simon MA; Adewole IF; Hou L; Murphy RL
Infect Agent Cancer; 2019; 14():43. PubMed ID: 31798680
[TBL] [Abstract][Full Text] [Related]
38. Social disparities in access to breast and cervical cancer screening by women living in Spain.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
[TBL] [Abstract][Full Text] [Related]
39. Determinants of Cervical Cancer Screening Among Women Aged 30-49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis.
Alie MS; Negesse Y; Ayenew M
Cancer Control; 2023; 30():10732748231195681. PubMed ID: 37656980
[TBL] [Abstract][Full Text] [Related]
40. Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years.
Kim JY; Hong J; Yoon J; Park J; Kim TH
J Gynecol Oncol; 2024 Mar; 35(2):e18. PubMed ID: 37921602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
